Ignite Creation Date:
2024-05-06 @ 2:56 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04477291
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-15
First Post:
2020-07-13
Brief Title:
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
Sponsor:
Aptose Biosciences Inc
Organization:
Aptose Biosciences Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| Luxeptinib | View |
| CG-806 | View |
| Aptose | View |
| FLT3 | View |
| FLT3-ITD | View |
| D835Y | View |
| F691L | View |
| BTK | View |
| C481S | View |
| TP53 | View |
| NRAS | View |
| IDH1 | View |
| BCL2 | View |
| Gilteritinib | View |
| Quizartinib | View |
| Midostaurin | View |
| Crenolanib | View |
| Venetoclax | View |
| Ibrutinib | View |
| Acalabrutinib | View |
| Zanubrutinib | View |
| LOXO-305 | View |
| ARQ 531 | View |
| AML | View |
| Acute Myeloid Leukemia | View |
| MDS | View |
| Myelodysplastic Syndrome | View |
| CLL | View |
| Chronic Lymphocytic Leukemia | View |
| Resistant | View |
| Refractory | View |
| Relapsed | View |
| Intolerant | View |
| Kinase Inhibitor | View |
| Non covalent | View |